Johnson & Johnson
JNJ
$0.52 (0.20%)
1D
1W
3M
1Y
5Y
ALL
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 8 hours ago • JNJ
4 Non-Tech Stocks to Grab as Dow Hits New Milestone Amid AI Sell-off
Business Wire • 8 hours ago • JNJ
Johnson & Johnson's Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September
24/7 Wall Street • 10 hours ago • JNJ
5 Dividend Stocks Every Boomer Should Own Heading Into Fall
Seeking Alpha • 1 day ago • JNJ
Johnson & Johnson (JNJ) Discusses FDA Authorization and Market Introduction of OTTAVA Robotic Surgical System Transcript
Zacks Investment Research • 1 day ago • JNJ
J&J's Strong Q2 Oncology Performance Fuels Future Growth Hopes
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.